- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.05. | Sentante wins CE mark for endovascular surgical robot | ||
| 20.05. | Medtronic study backs Evolut Tavr head-to-head against Edwards Sapien | ||
| 19.05. | Zenflow findings back BPH treatment device | ||
| 19.05. | Endologix acquires Pounce thrombectomy system from Surmodics | ||
| 19.05. | Cagent Vascular reports first-in-human IVL cases, closes $41M Series D | ||
| 19.05. | Resmed, Oura partner on sleep health education, care | ||
| 19.05. | Elixir Medical study backs DynamX bioadaptor against drug-eluting stent | ||
| 19.05. | Boston Scientific study of Seismiq coronary IVL meets endpoints | ||
| 18.05. | Medtronic Neuroscience head Brett Wall to depart, replacement named | ||
| 18.05. | Stryker enrolls first patient in first-in-human study of AVS IVL in a coronary indication | ||
| 18.05. | Design thinking in medtech: How to build for adoption and stickiness | ||
| 18.05. | Galvanize Therapeutics wins FDA nod for pulsed electric field generator for surgical ablation | ||
| 18.05. | Philips introduces SmartIQ imaging tech for Azurion image-guided therapy | ||
| 18.05. | EmStop initiates IDE study of novel embolic protection device | ||
| 18.05. | Artivion closes $175M acquisition of aortic arch maker Endospan | ||
| 18.05. | Dexcom launches Flex CGM for type 2 diabetes in Germany | ||
| 18.05. | BD taps former J&J leader as new president of Interventional | ||
| 18.05. | Boston Scientific invests $1.5B in TAVR developer MiRus, enters $2B share repurchase agreement | ||
| 15.05. | Philips CMO Dr. Carla Goulart Peron to keynote at DeviceTalks Boston | ||
| 15.05. | Dexcom unveils next-gen G8 CGM system, CEO Jake Leach explains new tech | ||
| 15.05. | Sonomotion wins updated FDA nod for lithotripsy device for kidney stones, trial meets endpoints | ||
| 15.05. | Butterfly Medical raises $21M for BPH device | ||
| 15.05. | CVRx earns Humana Medicare Advantage win for Barostim | ||
| 15.05. | BlueWind Medical raises $47.8M to support Revi commercialization | ||
| 15.05. | NinaMED raises $13.5M to support neuromod for overactive bladder licensed from EBT Medical |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.